Logo image of KINS

KINGSTONE COS INC (KINS) Stock Fundamental Analysis

NASDAQ:KINS - Nasdaq - US4967191051 - Common Stock - Currency: USD

14.5  -0.29 (-1.96%)

After market: 14.7 +0.2 (+1.38%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to KINS. KINS was compared to 145 industry peers in the Insurance industry. Both the profitability and the financial health of KINS get a neutral evaluation. Nothing too spectacular is happening here. KINS is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year KINS was profitable.
KINS had a positive operating cash flow in the past year.
In multiple years KINS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: KINS reported negative operating cash flow in multiple years.
KINS Yearly Net Income VS EBIT VS OCF VS FCFKINS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

With an excellent Return On Assets value of 5.40%, KINS belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
KINS has a better Return On Equity (25.32%) than 93.79% of its industry peers.
With an excellent Return On Invested Capital value of 6.23%, KINS belongs to the best of the industry, outperforming 87.59% of the companies in the same industry.
Industry RankSector Rank
ROA 5.4%
ROE 25.32%
ROIC 6.23%
ROA(3y)-1.36%
ROA(5y)-1.2%
ROE(3y)-17.5%
ROE(5y)-12.24%
ROIC(3y)N/A
ROIC(5y)N/A
KINS Yearly ROA, ROE, ROICKINS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

KINS's Profit Margin of 12.25% is fine compared to the rest of the industry. KINS outperforms 73.10% of its industry peers.
KINS's Operating Margin of 17.32% is fine compared to the rest of the industry. KINS outperforms 75.17% of its industry peers.
Industry RankSector Rank
OM 17.32%
PM (TTM) 12.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KINS Yearly Profit, Operating, Gross MarginsKINS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KINS is destroying value.
KINS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for KINS has been increased compared to 5 years ago.
KINS has a better debt/assets ratio than last year.
KINS Yearly Shares OutstandingKINS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
KINS Yearly Total Debt VS Total AssetsKINS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

The Debt to FCF ratio of KINS is 0.08, which is an excellent value as it means it would take KINS, only 0.08 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.08, KINS belongs to the best of the industry, outperforming 92.41% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that KINS is not too dependend on debt financing.
The Debt to Equity ratio of KINS (0.07) is better than 80.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.08
Altman-Z N/A
ROIC/WACC0.68
WACC9.22%
KINS Yearly LT Debt VS Equity VS FCFKINS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
KINS Yearly Current Assets VS Current LiabilitesKINS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

6

3. Growth

3.1 Past

KINS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1481.82%, which is quite impressive.
KINS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.52%.
KINS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.35% yearly.
EPS 1Y (TTM)1481.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%142.86%
Revenue 1Y (TTM)18.52%
Revenue growth 3Y-1.27%
Revenue growth 5Y1.35%
Sales Q2Q%70.56%

3.2 Future

The Earnings Per Share is expected to grow by 32.66% on average over the next years. This is a very strong growth
Based on estimates for the next years, KINS will show a very strong growth in Revenue. The Revenue will grow by 25.19% on average per year.
EPS Next Y43.66%
EPS Next 2Y32.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year39.52%
Revenue Next 2Y25.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KINS Yearly Revenue VS EstimatesKINS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
KINS Yearly EPS VS EstimatesKINS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.54, the valuation of KINS can be described as very reasonable.
KINS's Price/Earnings ratio is a bit cheaper when compared to the industry. KINS is cheaper than 67.59% of the companies in the same industry.
KINS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
With a Price/Forward Earnings ratio of 5.80, the valuation of KINS can be described as very cheap.
76.55% of the companies in the same industry are more expensive than KINS, based on the Price/Forward Earnings ratio.
KINS is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.54
Fwd PE 5.8
KINS Price Earnings VS Forward Price EarningsKINS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KINS is valued a bit cheaper than the industry average as 77.93% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, KINS is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.03
EV/EBITDA 5.36
KINS Per share dataKINS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KINS's earnings are expected to grow with 32.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y32.66%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

KINS has a Yearly Dividend Yield of 5.25%, which is a nice return.
Compared to an average industry Dividend Yield of 3.67, KINS pays a bit more dividend than its industry peers.
KINS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 5.25%

5.2 History

KINS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KINS Yearly Dividends per shareKINS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y32.66%
EPS Next 3YN/A
KINS Yearly Income VS Free CF VS DividendKINS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

KINGSTONE COS INC

NASDAQ:KINS (7/11/2025, 8:00:02 PM)

After market: 14.7 +0.2 (+1.38%)

14.5

-0.29 (-1.96%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-13 2025-05-13/dmh
Earnings (Next)08-07 2025-08-07/amc
Inst Owners37.1%
Inst Owner Change0%
Ins Owners9.77%
Ins Owner Change3.48%
Market Cap203.15M
Analysts85.71
Price Target22.44 (54.76%)
Short Float %3.05%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield 5.25%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.28%
Min Revenue beat(2)-2.9%
Max Revenue beat(2)-1.66%
Revenue beat(4)1
Avg Revenue beat(4)-4.96%
Min Revenue beat(4)-51.81%
Max Revenue beat(4)36.55%
Revenue beat(8)3
Avg Revenue beat(8)-7.11%
Revenue beat(12)5
Avg Revenue beat(12)-2.09%
Revenue beat(16)8
Avg Revenue beat(16)0.33%
PT rev (1m)0%
PT rev (3m)15.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.78%
EPS NY rev (1m)5.26%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)-1.5%
Revenue NQ rev (3m)-1.5%
Revenue NY rev (1m)0.51%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE 9.54
Fwd PE 5.8
P/S 1.2
P/FCF 3.03
P/OCF 2.91
P/B 2.47
P/tB 2.49
EV/EBITDA 5.36
EPS(TTM)1.52
EY10.48%
EPS(NY)2.5
Fwd EY17.23%
FCF(TTM)4.79
FCFY33%
OCF(TTM)4.98
OCFY34.31%
SpS12.13
BVpS5.87
TBVpS5.83
PEG (NY)0.22
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 25.32%
ROCE 7.91%
ROIC 6.23%
ROICexc 6.93%
ROICexgc 8.69%
OM 17.32%
PM (TTM) 12.25%
GM N/A
FCFM 39.47%
ROA(3y)-1.36%
ROA(5y)-1.2%
ROE(3y)-17.5%
ROE(5y)-12.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.08
Debt/EBITDA 0.17
Cap/Depr 107.41%
Cap/Sales 1.57%
Interest Coverage 7.75
Cash Conversion 218.54%
Profit Quality 322.12%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC9.22%
ROIC/WACC0.68
Cap/Depr(3y)98.26%
Cap/Depr(5y)109.6%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1481.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%142.86%
EPS Next Y43.66%
EPS Next 2Y32.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.52%
Revenue growth 3Y-1.27%
Revenue growth 5Y1.35%
Sales Q2Q%70.56%
Revenue Next Year39.52%
Revenue Next 2Y25.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y522.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y594.79%
FCF growth 3Y40.97%
FCF growth 5Y16.49%
OCF growth 1Y432.11%
OCF growth 3Y33.51%
OCF growth 5Y14.18%